ROCKVILLE, Md.--(BUSINESS WIRE)--May 29, 2014--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of
the company’s senior management team will participate in the following
investor conferences in June 2014:
-
Jefferies 2014 Global Healthcare Conference
New York, NY
June
5, 2014
Presentation: 1:00PM Eastern
-
JMP Securities Healthcare Conference
New York, NY
June
24, 2014
Presentation: 4:00PM Eastern
-
Janney Capital Markets’ Boston Healthcare Corporate Access Day
Boston,
MA
June 26, 2014
For the Jefferies and JMP Securities conferences, the company will be
webcasting the formal portion of its participation, which may include a
discussion of the company's recent business developments as well as its
current financial results and financial guidance for the current year
and latest quarterly period. The webcasts will be available both live
and by replay, accessible from the Emergent website www.emergentbiosolutions.com
under “Investors.”
For the Janney Capital Markets conference, the company will only be
participating in one-on-one meetings. The conference format does not
include formal presentations.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking
to protect and enhance life by offering specialized products to
healthcare providers and governments to address medical needs and
emerging health threats. Additional information about the company may be
found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Vice President, Global Public
Affairs and Corporate Responsibility
301-795-1800
SchmittT@ebsi.com
